Hodnocení reperfuzní léčby u pacientů v akutní fázi infarktu myokardu s elevací ST-segmentu (STEMI) v pilotním registru infarktu myokardu

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F67985807%3A_____%2F08%3A00306276" target="_blank" >RIV/67985807:_____/08:00306276 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Reperfusion Therapy in ST-segment Elevation Myocardial Infarction ? Data from a Pilot Registry of Myocardial Infarction

Popis výsledku v původním jazyce

Methods: A total of 744 consecutive patients with STEMI from years 2003?2006 were included in the study. Also, data on their demographics and reperfusion strategy were collected. An assessed clinical outcome was in-hospital mortality. Results: The mean age of STEMI patients was 66.9 +/- 2.6 years. The vast majority were men (62.4%). A total of 68.6% STEMI patients received primary reperfusion treatment, 97.0% of them were referred for PPCI and 3.6% were treated with fibrinolytic therapy. Women and elderly patients were less likely to receive reperfusion therapy. The in-hospital mortality was 11.3% for all STEMI patients; 3.5% in reperfused and 25.7% in non-reperfused group (p < 0.001). When adjusting for age, the effect of reperfusion therapy remainedsignificant. Conclusions: In-hospital mortality was significantly reduced in a subgroup of patients who underwent primary reperfusion treatment (PPCI or fibrinolytic therapy).

Název v anglickém jazyce

Reperfusion Therapy in ST-segment Elevation Myocardial Infarction ? Data from a Pilot Registry of Myocardial Infarction

Popis výsledku anglicky

Methods: A total of 744 consecutive patients with STEMI from years 2003?2006 were included in the study. Also, data on their demographics and reperfusion strategy were collected. An assessed clinical outcome was in-hospital mortality. Results: The mean age of STEMI patients was 66.9 +/- 2.6 years. The vast majority were men (62.4%). A total of 68.6% STEMI patients received primary reperfusion treatment, 97.0% of them were referred for PPCI and 3.6% were treated with fibrinolytic therapy. Women and elderly patients were less likely to receive reperfusion therapy. The in-hospital mortality was 11.3% for all STEMI patients; 3.5% in reperfused and 25.7% in non-reperfused group (p < 0.001). When adjusting for age, the effect of reperfusion therapy remainedsignificant. Conclusions: In-hospital mortality was significantly reduced in a subgroup of patients who underwent primary reperfusion treatment (PPCI or fibrinolytic therapy).

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

BB - Aplikovaná statistika, operační výzkum

OECD FORD obor

—

Projekt

<a href="/cs/project/1M06014" target="_blank" >1M06014: Centrum biomedicínské informatiky (CBI)</a><br>

Návaznosti

Z - Vyzkumny zamer (s odkazem do CEZ)

Rok uplatnění

2008

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

—

Svazek periodika

Roc. 50

Číslo periodika v rámci svazku

c. 2

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

5

Strana od-do

55-59

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—